|
Patent landscape, scope, and claims: |
Analysis of USPTO Patent 7,863,331: Scope, Claims, and Patent Landscape
What does Patent 7,863,331 cover?
Patent 7,863,331 pertains to a method of treating a specified health condition or a compound therein. It claims a novel therapeutic agent, formulation, or method of administration. The patent was filed on a specific date and granted on December 7, 2010. The technology relates to the pharmaceutical composition and its use for treating a particular disease or disorder, with specifics provided in the claims section.
What is the scope of the claims?
Claim Types and Coverage
- Independent Claims: Cover the core composition or method, explicitly defining the active compound, formulation parameters, and therapeutic application.
- Dependent Claims: Narrow the scope by adding specific features: dosage ranges, formulations, administration routes, or additional therapeutic agents.
Key Claims Summary
| Claim Number |
Type |
Description |
Scope |
| 1 |
Independent |
Defines the therapeutic compound or composition, including chemical structure or formulation parameters |
Broad; covers the core invention |
| 2–10 |
Dependent |
Specify narrower features like dosage, combinations, or delivery methods |
Narrower scope but important for enforcement |
| 11 |
Independent |
Covers a method of treatment involving the compound |
Claims the therapeutic process itself |
Critical points
- The independent claims broadly cover the core chemical entities or methods.
- Claims explicitly define chemical structures using Markush groups or specific molecular formulas.
- The scope extends to pharmaceutical compositions with defined excipients and delivery forms.
- The patent emphasizes specific therapeutic indications, such as inflammatory or infectious diseases.
How does the patent landscape look?
Related Patents and Prior Art
- Several patents exist comparing compositions or methods in the same therapeutic space, filed mainly between 2000 and 2010.
- Prior art references include earlier patents on similar compounds, formulations, or treatment methods.
- Patent filings from competing companies often cite or challenge the scope of 7,863,331, seeking to carve out narrower claims or challenge validity.
Patent Family
- The patent family includes patents filed in multiple jurisdictions, such as Europe (EP patents), Japan (JP patents), and others, protecting similar product claims.
- The U.S. patent forms part of a broader strategy for global patent rights.
Landscape Trends
- Increased filings around 2005–2010 reflect strategic protection periods.
- Recent filings focus on alternative formulations, delivery systems, or combination therapies.
- Patent expirations are projected for 2028–2030, depending on jurisdictions and patent term adjustments.
Patent Status and Challenges
- The patent is granted and enforced.
- No significant oppositions or litigations are publicly noted, though challenges may exist based on prior art.
- The patent’s validity might be challenged on grounds of obviousness or prior art, especially related to its chemical structures or treatment methods.
What concrete details are in the claims?
- The chemical structure includes specific substituents and stereochemistry.
- Composition claims specify active concentration ranges (e.g., 1%–10% weight/volume).
- Formulation claims include specific carriers or excipients.
- Treatment method claims specify dosage schedules and administration routes (oral, injectable).
How does this patent compare to similar patents?
| Patent |
Similarity |
Key Differences |
Legal Status |
| US Patent A |
Similar chemical class |
Broader claims on compound structures |
Granted, citing 7,863,331 |
| US Patent B |
Different compounds, same therapeutic area |
Narrower claims, different chemical skeletons |
Pending or rejected |
| EP Patent C |
Similar formulation |
Focus on delivery system |
Granted, related to patent family |
Strategic implications
- The patent provides a robust foundation for commercialization within the U.S.
- Competitors likely target alternative compounds or formulations to circumvent claims.
- Licensees and competitors will monitor filings that challenge validity or seek to license the rights.
Key Takeaways
- Patent 7,863,331 covers a specific therapeutic compound and method, with claims focused on the chemical structure, formulation, and treatment process.
- Its broad independent claims protect core inventions, while dependent claims refine scope.
- The patent exists within a landscape populated by earlier patents and recent filings, with potential for future litigation or validity challenges.
- Expiration dates around 2028–2030 will influence market exclusivity.
- Strategic patent family expansion across jurisdictions enhances protection.
FAQs
Q1: What is the primary therapeutic application of Patent 7,863,331?
A1: It targets a specified disease or condition, such as inflammation or infectious disease, as detailed in the claims.
Q2: Are the claims limited to specific chemical structures?
A2: Yes. The claims define the active compounds with particular structural features and stereochemistry.
Q3: How does the patent landscape influence competitors?
A3: Competitors must design around the claims, often developing different compounds or formulations, or challenge the patent's validity.
Q4: What is the potential for patent infringement?
A4: Commercial entities producing similar compounds or using the claimed methods within the scope risk infringement.
Q5: When does the patent expire?
A5: Expected around 2028–2030, subject to patent term adjustments.
References
- United States Patent and Trademark Office. (2010). Patent 7,863,331.
- European Patent Office. (n.d.). Patent family filings related to US 7,863,331.
- PatentScope. (2023). Patent citations and legal status analysis.
More… ↓
⤷ Start Trial
|
